Clinical Evaluation of Targeted Arterial Infusion of Verapamil in the Interventional Chemotherapy of Primary Hepatocellular Carcinoma

Cell Biochemistry and Biophysics

Volumn 59, Issue 2, 2011, Pages 127-132

  Huang, Jin ^a   Duan, Qiaohong ^a   Fan, Pingsheng ^a   Ji, Chushu ^b   Lv, Yuying ^a   Lin, Xinmin ^b   Qian, Liting ^b   Yu, Xiukun ^a  

^a Anhui Tumour Hospital   (China)

^b ANHUI PROVINCIAL HOSPITAL   (China)

Author keywords

Arterial perfusion; Multiple drug resistance; P glycoprotein; Primary hepatocellular carcinoma; Verapamil

Indexed keywords

ANTINEOPLASTIC AGENT; VERAPAMIL;

ARTICLE; BODY WEIGHT; CANCER STAGING; CLINICAL TRIAL; DISEASE COURSE; DRUG RESISTANCE; ELECTROCARDIOGRAPHY; FEMALE; HEART MUSCLE; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; METABOLISM; MULTIDRUG RESISTANCE; PATHOLOGY; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS; BODY WEIGHT; CARCINOMA, HEPATOCELLULAR; DISEASE PROGRESSION; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; INFUSIONS, INTRA-ARTERIAL; LIVER NEOPLASMS; MALE; MYOCARDIUM; NEOPLASM STAGING; TREATMENT OUTCOME; VERAPAMIL;

EID: 79951854586     PISSN: 10859195     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12013-010-9125-9     Document Type: Article

References (24)

1. Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2005). Global cancer statistics, 2002. CA: A Cancer Journal for Clinicians, 55, 74-108.
2. Llovet, J. M., Bruix, J., & Gores, G. J. (2000). Surgical resection versus transplantation for early hepatocellular carcinoma: Clues for the best strategy. Hepatology, 31, 1019-1021.
3. Veltri, A., Moretto, P., Doriguzzi, A., Pagano, E., Carrara, G., & Gandini, G. (2006). Radiofrequency thermal ablation (RFA) after transarterial chemoembolization (TACE) as a combined therapy for unresectable non-early hepatocellular carcinoma (HCC). European Radiology, 16, 661-669.
4. Vogl, T. J., Naguib, N. N., Nour-Eldin, N. E., Rao, P., Emami, A. H., Zangos, S., et al. (2009). Review on transarterial chemoembolization in hepatocellular carcinoma: Palliative, combined, neoadjuvant, bridging, and symptomatic indications. European Journal of Radiology, 72, 505-516.
5. Goldstein, H. M., Wallace, S., Anderson, J. H., Bree, R. L., & Gianturco, C. (1976). Transcatheter occlusion of abdominal tumors. Radiology, 120, 539-545.
6. Buijs, M., Vossen, J. A., Frangakis, C., Hong, K., Georgiades, C. S., Chen, Y., et al. (2008). Nonresectable hepatocellular carcinoma: Long-term toxicity in patients treated with transarterial chemoembolization-single-center experience. Radiology, 249, 346-354.
7. Kirchhoff, T. D., Bleck, J. S., Dettmer, A., Chavan, A., Rosenthal, H., Merkesdal, S., et al. (2007). Transarterial chemoembolization using degradable starch microspheres and iodized oil in the treatment of advanced hepatocellular carcinoma: Evaluation of tumor response, toxicity, and survival. Hepatobiliary and Pancreatic Diseases International, 6, 259-266.
8. Liu, Y. M., Qin, H., Wang, C. B., Fang, X. H., & Ma, Q. Y. (2006). Comparison of therapeutic effectiveness of combined interventional therapy for 1126 cases of primary liver cancer. World Journal of Gastroenterology, 12, 5060-5063.
9. Chen, L., Zuo, G. Q., Wu, J. F., Zeng, G. L., Li, T., Liu, Z. J., et al. (2009). Intercellular transfer of P-glycoprotein in hepatocellular cell line HepG2. Zhonghua Gan Zang Bing Za Zhi [Article in Chinese], 17, 839-842.
10. Yan, F., Wang, X. M., Liu, Z. C., Pan, C., Yuan, S. B., & Ma, Q. M. (2010). JNK1, JNK2 and JNK3 are involved in P-glycoprotein-mediated multidrug resistance of hepatocellular carcinoma cells. Hepatobiliary and Pancreatic Diseases International, 9, 287-295.
11. Sun, Z., Zhao, Z., Li, G., Dong, S., Huang, Z., Ye, L., et al. (2010). Relevance of two genes in the multidrug resistance of hepatocellular carcinoma: In vivo and clinical studies. Tumori, 96, 90-96.
12. Ford, J. M., & Hait, W. N. (1990). Pharmacology of drugs that alter multidrug resistance in cancer. Pharmacological Reviews, 42, 155-199.
13. Baumert, C., & Hilgeroth, A. (2009). Recent advances in the development of P-gp inhibitors. Anti-Cancer Agents in Medicinal Chemistry, 9, 415-436.
14. Fety, R., Lucas, C., Solere, P., Cour, V., & Vignoud, J. (1992). Hepatic intra-arterial infusion of fotemustine: Pharmacokinetics. Cancer Chemotherapy and Pharmacology, 31, 118-122.
15. Mori, T., Iwasaki, Y., Takahashi, K., & Takahashi, T. (1992). Experimental study on adequate 5-FU dose and flow volume for continuous arterial liver infusion. Gan To Kagaku Ryoho [Article in Japanese], 19, 1547-1549.
16. Fan, P., & Feng, K. (2004). The effect of hepatic artery infusion of verapamil on the canine vital signs and drug blood concentration. J Cancer, 3, 241-244.
17. Miura, T., An, M., Matsumoto, Y., Terakado, H., Murata, M., Takagi, S., et al. (1998). Transcatheter oily chemoembolization and intermittent hepatic artery infusion chemotherapy in the management of advanced hepatocellular carcinoma. Gan To Kagaku Ryoho [Article in Japanese], 25, 1262-1265.
18. Professional Committee of Chinese Anti-Cancer Association of liver cancer. (2001). Clinical diagnostic/staging criteria of primary liver cancer. Zhonghua Gan Zang Bing Za Zhi [In Chinese], 9, 324.
19. Trotti, A., Byhardt, R., Stetz, J., Gwede, C., Corn, B., Fu, K., et al. (2000). Common toxicity criteria: version 2. 0, an improved reference for grading the acute effects of cancer treatment: impact on radiotherapy. International Journal of Radiation Oncology, Biology, Physics, 47, 13-47.
20. The Criteria Committee of the New York Heart Association. (1994). Nomenclature and Criteria for Diagnosis of Diseases of the Heart and Great Vessels (9th ed., pp. 253-256). Boston: Mass. Little Brown & Co.
21. Pugh, R. N. H., Murray-Lyon, I. M., Dawson, J. L., Pietroni, M. C., & Williams, R. (1973). Transection of the esophagus for bleeding esophageal varises. British Journal of Surgery, 60, 648-652.
22. Interventional Radiology Group Editorial Board of Chinese Medical Association Radiology. (2001). Interventional therapy for standardization (Draft). The Journal of Radiology, 35, 230-231.
23. Shi, H., Lu, D., Shu, Y., Shi, W., Lu, S., & Wang, K. (2008). Expression of multidrug resistance-related proteins p-glycoproteinglutathione-s-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma. Cancer Investigation, 26, 344-351.
24. Liu, J., & Chen, X. (2000). Hepatocellular carcinoma multidrug resistance gene expression and its significance. Journal of Experimental and Clinical Cancer Research, 17, 406-408.